A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

A new study has revealed that GLP-1 drugs, commonly used for diabetes and weight loss, show promise in treating alcohol ...

Novo Nordisk, which manufactures weight-loss drug Wegovy and diabetes medication Ozempic, has asked the US authorities to ...

The popular weight loss drugs have also been found to reduce other risks, including the risk of death from COVID-19.

Some GLP-1 receptor agonists may hold promise as treatments for alcohol use disorder (AUD), a Swedish observational study ...

Ro details dietary choices that may help Wegovy's capacity to regulate appetite and foster a healthier weight as well as ...

Stopping semaglutide, marketed as Wegovy and Ozempic, which helps people lose weight , can have severe health impacts, a new ...

A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists ...

Semaglutide and liraglutide are associated with reduced AUD and SUD-related hospitalization risks, unlike other GLP-1 ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

Hims & Hers (HIMS) has launched an online GLP-1 supply tracker where people can share information about where the popular ...